US 11857535
Methods of treating mutant lymphomas
granted A61KA61K31/404A61K31/4545
Quick answer
US patent 11857535 (Methods of treating mutant lymphomas) held by Kymera Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/404, A61K31/4545, A61P, A61P35/00